Outgoing Bush administration Health and Human Services (HHS) Secretary Mike Leavitt and Department of Homeland Security director Mike Chertoff provided the Obama transition team’s "Homeland Security Council" with their the 50-page report, "Assessment of States’ Operating Plans to Combat Pandemic Influenza" (Jan., 2009).

In the report, BOTH Leavitt and Chertoff issued a joint statement; declaring that "the pandemic threat is real and continuing, irrespective of how the perception of the threat may wax or wane over time."

The information presented in this report, combined with an accompanying press release and periodic media hype, indicate that a premeditated, human-created global influenza pandemic is still under consideration.

Concurrent with the release of the report, HHS Secretary Leavitt also issued a press release Jan. 11, 2009, announcing that the Bush administration had approved a "$487 million dollar contract with Novartis Pharmaceutical of Basel, Switzerland, to build the first U.S. manufacturing facility for cell-based influenza vaccine in North Carolina.

To understand the true nature of this "new construction" one needs to understand the history of Novartis Pharmaceuticals Inc. and how the new facility fits into the development of cell-based influenza vaccine which, I believe, will be used to trigger (rather than prevent) a global influenza pandemic.

Novartis was created in 1996 from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss pharmaceutical companies.

Ciba-Geigy and Sandoz were originally German entities and integral pillars of the massive Rothschild and Rockefeller "Syndicate of Dyestuff-Industry Corporations" (the German translation for which is "InteressenGemeinschaft Farben," better known as "I.G. Farben"). Scholars of Hitler’s rise to power have long credited massive corporate capital transferred via I.G. Farben’s Swiss Corporate banking accounts as the primary vehicle that financed the Third Reich. In fact, it was Sandoz Lab’s Swiss accounts that enabled investigators to successfully indict Prescott Bush (GHW’s father and GW’s grandfather) under the "Trading with the Enemy Act" in 1948 for collaborating with the Nazis in WWII.

Furthermore, it was established that in 1938, a new "wonder drug" was developed at Sandoz labs and tested by Dr. Josef Mengele et. al. in German concentration camps. This 1938 "wonder drug" is known today as lysergic acid diethylamide (LSD) 25 and with the expatriation of Nazi scientists to the U.S. under "Operation Paper Clip" in 1945, experimentation with LSD and human mind control techniques continued in America under the CIA’s "MK Ultra" program.

And now Novartis, the Swiss pharmaceutical company with I.G. Farben/ Ciba-Geigy and Sandoz roots and their historical relationship with the Bush family, was awarded a Bush administration-approved contract to continue the development of cell-based influenza vaccine on American soil. The new cell-based flu vaccines being developed by Novartis are developed from human kidney cells rather than chicken embryo cells. As previously reported in The IO (July, 2008), the kidney cells Novartis has been using to propagate its cell-based influenza vaccine were harvested from impoverished Chinese peasants.

Published medical literature describes how the harvested human kidney cells are chemically preserved before finally being injected with a weaponized form of the 1918 "Spanish flu" pathogen, which has characteristics which could be called "avian." In this medium the virus grows until harvested and placed into vials as a "bird flu" vaccine. Also reported in the July, 2008 edition of The IO is the fact that Leavitt, using his "emergency powers" as HHS secretary, has already licensed this untested, experimental vaccine for production and deployment by government agencies though the vaccine has not been approved for sale in the private sector.

A. True Ott, ND, of Mother Earth Minerals, is also the editor of the "Health is your Wealth" newsletter. Dr. True Ott can be contacted by writing Mother Earth Minerals, 1260 S. 1200 W. #3, Ogden, UT 84404 or by calling (801) 392-1635.